Wang et al. (2017) first successfully corrected the FUS+/G1566A mutations in ALS iPSCs by CRISPR/Cas9 system, and the repaired ALS iPSCs possessed normal pluripotency. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.